Modulation of immunity by the secreted phospholipase A2 family

Among the phospholipase A2 (PLA2 ) superfamily, which typically catalyzes the sn-2 hydrolysis of phospholipids to yield fatty acids and lysophospholipids, the secreted PLA2 (sPLA2 ) family contains 11 isoforms in mammals. Individual sPLA2 s have unique enzymatic specificity toward fatty acids and polar heads of phospholipid substrates and display distinct tissue/cellular distributions, suggesting their distinct physiological functions. Recent studies using knockout and/or transgenic mice for a full set of sPLA2 s have revealed their roles in modulation of immunity and related disorders. Application of mass spectrometric lipidomics to these mice has enabled to identify target substrates and products of individual sPLA2 s in given tissue microenvironments. sPLA2 s hydrolyze not only phospholipids in the plasma membrane of activated, damaged or dying mammalian cells, but also extracellular phospholipids such as those in extracellular vesicles, microbe membranes, lipoproteins, surfactants, and dietary phospholipids, thereby exacerbating or ameliorating various diseases. The actions of sPLA2 s are dependent on, or independent of, the generation of fatty acid- or lysophospholipid-derived lipid mediators according to the pathophysiological contexts. In this review, we make an overview of our current understanding of the roles of individual sPLA2 s in various immune responses and associated diseases.

[1]  M. Lewin,et al.  The BRAVO Clinical Study Protocol: Oral Varespladib for Inhibition of Secretory Phospholipase A2 in the Treatment of Snakebite Envenoming , 2022, Toxins.

[2]  O. Kretz,et al.  Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice. , 2022, Kidney international.

[3]  S. Shinton,et al.  Pla2g2a promotes innate Th2-type immunity lymphocytes to increase B1a cells , 2022, Scientific Reports.

[4]  Y. Miki,et al.  Old but New: Group IIA Phospholipase A2 as a Modulator of Gut Microbiota , 2022, Metabolites.

[5]  Saumya Das,et al.  Making a sPLAsh: The expanding repertoire of EV signaling. , 2022, Cell metabolism.

[6]  A. Meola,et al.  Microbial Protein Binding to gC1qR Drives PLA2G1B-Induced CD4 T-Cell Anergy , 2022, Frontiers in Immunology.

[7]  Kristen Fortney,et al.  Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19 , 2022, Nature.

[8]  Y. Miki,et al.  Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma. , 2022, Cell metabolism.

[9]  M. Gelb,et al.  The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation , 2022, JCI insight.

[10]  K. Mizuguchi,et al.  Group IIA secreted phospholipase A2 controls skin carcinogenesis and psoriasis by shaping the gut microbiota , 2022, JCI insight.

[11]  I. Križaj,et al.  Secreted Phospholipases A2 - not just Enzymes: Revisited , 2022, International journal of biological sciences.

[12]  Xiaoyi Zhang,et al.  Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer , 2021, Frontiers in Oncology.

[13]  Yifan Yang,et al.  Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[14]  Y. Hannun,et al.  Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. , 2021, The Journal of clinical investigation.

[15]  Varnavas D. Mouchlis,et al.  Omega-3 versus Omega-6 fatty acid availability is controlled by hydrophobic site geometries of phospholipase A2s , 2021, Journal of lipid research.

[16]  H. Ueda,et al.  Secreted PLA2-III is a possible therapeutic target to treat neuropathic pain. , 2021, Biochemical and biophysical research communications.

[17]  M. Murakami,et al.  Mast Cell-Specific Deletion of Group III Secreted Phospholipase A2 Impairs Mast Cell Maturation and Functions , 2021, Cells.

[18]  E. Letsiou,et al.  Group V Phospholipase A2 Mediates Endothelial Dysfunction and Acute Lung Injury Caused by Methicillin-Resistant Staphylococcus Aureus , 2021, Cells.

[19]  L. Touqui,et al.  Role of human group IIA secreted phospholipase A2 in malaria pathophysiology: Insights from a transgenic mouse model. , 2021, Biochimie.

[20]  A. Oberg,et al.  Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization , 2021, Journal of experimental & clinical cancer research : CR.

[21]  M. Gelb,et al.  Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D. , 2021, The Journal of clinical investigation.

[22]  P. Dubus,et al.  PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during aging , 2021, Cell Death & Disease.

[23]  Tianyan You,et al.  Phospholipase A2 inhibitor–loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression , 2021, Science Advances.

[24]  Munehiro Yamaguchi,et al.  Lipid Profile of Activated Macrophages and Contribution of Group V Phospholipase A2 , 2020, Biomolecules.

[25]  H. Ueda.  Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain. , 2020, Progress in lipid research.

[26]  V. Bochkov,et al.  Synergy between 15-lipoxygenase and secreted PLA2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles , 2020, Proceedings of the National Academy of Sciences.

[27]  Zhi Wei,et al.  Paneth Cell-Derived Lysozyme Defines the Composition of Mucolytic Microbiota and the Inflammatory Tone of the Intestine. , 2020, Immunity.

[28]  Y. Miki,et al.  Secreted Phospholipase PLA2G2D Contributes to Metabolic Health by Mobilizing ω3 Polyunsaturated Fatty Acids in WAT. , 2020, Cell reports.

[29]  M. Gelb,et al.  Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung , 2020, The Journal of Immunology.

[30]  D. Fujioka,et al.  Deficiency of Phospholipase A2 Receptor Exacerbates Autoimmune Myocarditis in Mice , 2020, Inflammation.

[31]  Sayon Roy,et al.  Context-dependent effect of sPLA2-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer , 2019, EBioMedicine.

[32]  G. Lambeau,et al.  Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins , 2019, Infection and Immunity.

[33]  Varnavas D. Mouchlis,et al.  Phospholipase A2 catalysis and lipid mediator lipidomics. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[34]  M. Murakami.  Novel functions of phospholipase A2s: Overview. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[35]  Y. Miki,et al.  Group IID, IIE, IIF and III secreted phospholipase A2s☆ , 2018, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.

[36]  M. Bergo,et al.  Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes , 2018, Aging cell.

[37]  Jun Lu,et al.  Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma. , 2018, Blood.

[38]  Yiding Wang,et al.  Exploration of the Inhibitory Potential of Varespladib for Snakebite Envenomation , 2018, Molecules.

[39]  J. Mccammon,et al.  Membrane Allostery and Unique Hydrophobic Sites Promote Enzyme Substrate Specificity , 2018, Journal of the American Chemical Society.

[40]  J. Boyce,et al.  Macrophages regulate lung ILC2 activation via Pla2g5-dependent mechanisms , 2017, Mucosal Immunology.

[41]  M. Murakami,et al.  Lipoquality control by phospholipase A2 enzymes , 2017, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[42]  M. Gelb,et al.  Secreted PLA2 group X orchestrates innate and adaptive immune responses to inhaled allergen. , 2017, JCI insight.

[43]  L. Collinson,et al.  Epithelial-Cell-Derived Phospholipase A2 Group 1B Is an Endogenous Anthelmintic , 2017, Cell Host and Microbe.

[44]  Y. Miki,et al.  Group III phospholipase A2 promotes colitis and colorectal cancer , 2017, Scientific Reports.

[45]  T. Quesada-López,et al.  The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes , 2016, Nature Communications.

[46]  M. Lewin,et al.  Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation , 2016, Toxins.

[47]  N. Selmi,et al.  Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease , 2016, ACS medicinal chemistry letters.

[48]  Huiping Zhang,et al.  Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China , 2016, PloS one.

[49]  M. Gelb,et al.  Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors with Distinct Roles in Homeostasis, Inflammation, and Cancer. , 2016, Cell stem cell.

[50]  K. Honda,et al.  The microbiota in adaptive immune homeostasis and disease , 2016, Nature.

[51]  V. Sperandio,et al.  Interactions between the microbiota and pathogenic bacteria in the gut , 2016, Nature.

[52]  M. Gelb,et al.  Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection , 2015, The Journal of experimental medicine.

[53]  M. Gelb,et al.  The role of group IIF-secreted phospholipase A2 in epidermal homeostasis and hyperplasia , 2015, The Journal of experimental medicine.

[54]  K. Yokote,et al.  Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1. , 2015, Cell reports.

[55]  M. Gelb,et al.  Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA , 2015, Proceedings of the National Academy of Sciences.

[56]  M. Murakami,et al.  Phospholipase A2 Group III and Group X Have Opposing Associations with Prognosis in Colorectal Cancer. , 2015, Anticancer research.

[57]  J. Balsinde,et al.  Group V Secreted Phospholipase A2 Is Upregulated by IL-4 in Human Macrophages and Mediates Phagocytosis via Hydrolysis of Ethanolamine Phospholipids , 2015, The Journal of Immunology.

[58]  J. Tao,et al.  Group IIE secretory phospholipase A2 regulates lipolysis in adipocytes , 2015, Obesity.

[59]  G. Lambeau,et al.  Secreted phospholipases A2 in cancer: diverse mechanisms of action. , 2014, Biochimie.

[60]  D. Leduc,et al.  Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity , 2014, Nature Communications.

[61]  Nataliya Gorinski,et al.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells , 2014, Nature Medicine.

[62]  M. Gelb,et al.  Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. , 2014, Blood.

[63]  M. Gelb,et al.  The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity. , 2014, Cell metabolism.

[64]  R. Evans,et al.  A Gpr120 Selective Agonist Improves Insulin Resistance and Chronic Inflammation , 2014, Nature Medicine.

[65]  D. Hui,et al.  Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice. , 2014, Atherosclerosis.

[66]  M. Gelb,et al.  sPLA2 and the epidermal barrier. , 2014, Biochimica et biophysica acta.

[67]  Stephen S. H. Huang,et al.  Lack of group X secreted phospholipase A2 increases survival following pandemic H1N1 influenza infection , 2014, Virology.

[68]  E. Shin,et al.  Distribution of Secretory Phospholipase A2 XIIA in the Brain and its Role in Lipid Metabolism and Cognition , 2014, Molecular Neurobiology.

[69]  Guillaume Devailly,et al.  Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth , 2014, Oncotarget.

[70]  J. Kastelein,et al.  Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. , 2014, JAMA.

[71]  J. Heeren,et al.  Adipose tissue browning and metabolic health , 2014, Nature Reviews Endocrinology.

[72]  D. Bernard,et al.  PLA2R1 kills cancer cells by inducing mitochondrial stress. , 2013, Free radical biology & medicine.

[73]  R. Medzhitov,et al.  Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. , 2013, Immunity.

[74]  M. Murakami,et al.  This information is current as Inflammation Exacerbates Ovalbumin-Induced Lung Receptor 2 Deficiency of Phospholipase , 2013 .

[75]  Zhigang Tian,et al.  Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. , 2013, Immunity.

[76]  W. Xing,et al.  Group V Secretory Phospholipase A2 Is Involved in Macrophage Activation and Is Sufficient for Macrophage Effector Functions in Allergic Pulmonary Inflammation , 2013, The Journal of Immunology.

[77]  M. Gelb,et al.  Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators , 2013, The Journal of experimental medicine.

[78]  A. Birukova,et al.  Mechanical induction of group V phospholipase A(2) causes lung inflammation and acute lung injury. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[79]  M. Gelb,et al.  Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2–DP1 receptor paracrine axis , 2013, Nature Immunology.

[80]  A. Chawla,et al.  The immune system as a sensor of the metabolic state. , 2013, Immunity.

[81]  Kei Yamamoto,et al.  Group X Secreted Phospholipase A2 Limits the Development of Atherosclerosis in LDL Receptor–Null Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[82]  James G. Bollinger,et al.  Key Role of Group V Secreted Phospholipase A2 in Th2 Cytokine and Dendritic Cell-Driven Airway Hyperresponsiveness and Remodeling , 2013, PloS one.

[83]  P. Shridas,et al.  Vascular Biology , Atherosclerosis , and Endothelium Biology Group V Secretory Phospholipase A 2 Enhances the Progression of Angiotensin II – Induced Abdominal Aortic Aneurysms but Confers Protection against Angiotensin II – Induced Cardiac Fibrosis in ApoE-Deficient Mice , 2012 .

[84]  J. Hampe,et al.  Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity , 2012, Nature Medicine.

[85]  P. Elliott,et al.  Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human , 2012, Nature.

[86]  J. Obata,et al.  Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice. , 2012, American journal of physiology. Heart and circulatory physiology.

[87]  L. Touqui,et al.  A Novel Bacterial Resistance Mechanism against Human Group IIA-Secreted Phospholipase A2: Role of Streptococcus pyogenes Sortase A , 2011, The Journal of Immunology.

[88]  G. Holder,et al.  Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina. , 2011, American journal of human genetics.

[89]  E. Dennis,et al.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. , 2011, Chemical reviews.

[90]  S. Narumiya,et al.  Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. , 2011, The American journal of pathology.

[91]  M. Gelb,et al.  Group X Secretory Phospholipase A2 Enhances TLR4 Signaling in Macrophages , 2011, The Journal of Immunology.

[92]  James G. Bollinger,et al.  Blockade of Human Group X Secreted Phospholipase A2 (GX-sPLA2)-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA2 Inhibitor* , 2011, The Journal of Biological Chemistry.

[93]  W. Henderson,et al.  Relationship between levels of secreted phospholipase A2 groups IIA and X in the airways and asthma severity , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[94]  D. Hui,et al.  Pancreatic acinar cell-specific overexpression of group 1B phospholipase A2 exacerbates diet-induced obesity and insulin resistance in mice , 2011, International Journal of Obesity.

[95]  J. Obata,et al.  Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. , 2011, Cardiovascular research.

[96]  Y. Miki,et al.  Recent progress in phospholipase A₂ research: from cells to animals to humans. , 2011, Progress in lipid research.

[97]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[98]  Kei Yamamoto,et al.  Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics , 2011, Analytical and bioanalytical chemistry.

[99]  Chi-wai Wong,et al.  Hepatocyte nuclear factor‐4 alpha regulates liver triglyceride metabolism in part through secreted phospholipase A2 GXIIB , 2011, Hepatology.

[100]  M. Gelb,et al.  Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. , 2011, Atherosclerosis.

[101]  Xia Li,et al.  Group X secretory phospholipase A2 negatively regulates adipogenesis in murine models , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[102]  D. Fujioka,et al.  Group V Secretory Phospholipase A2 Reveals Its Role in House Dust Mite-Induced Allergic Pulmonary Inflammation by Regulation of Dendritic Cell Function , 2010, The Journal of Immunology.

[103]  M. Gelb,et al.  Group X Secretory Phospholipase A2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in Macrophages , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[104]  J. Tanguay,et al.  Group V secreted phospholipase A2 contributes to LPS‐induced leukocyte recruitment , 2010, Journal of cellular physiology.

[105]  P. Pfluger,et al.  Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet‐induced obesity , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[106]  G. Graham,et al.  Emerging roles for phospholipase A2 enzymes in cancer. , 2010, Biochimie.

[107]  Daisuke Fujioka,et al.  A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis , 2010, EMBO molecular medicine.

[108]  T. Ideker,et al.  Functional genomic screen for modulators of ciliogenesis and cilium length , 2010, Nature.

[109]  F. Clavel-Chapelon,et al.  Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk. , 2010, Carcinogenesis.

[110]  D. Charmot,et al.  The phospholipase A2 inhibitor methyl indoxam suppresses diet‐induced obesity and glucose intolerance in mice , 2009, British journal of pharmacology.

[111]  M. Kurrer,et al.  Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells , 2009, Proceedings of the National Academy of Sciences.

[112]  M. Gelb,et al.  Group V Secretory Phospholipase A2 Modulates Phagosome Maturation and Regulates the Innate Immune Response against Candida albicans 1 , 2009, The Journal of Immunology.

[113]  K. Forrest,et al.  The Capacity of Group V sPLA2 to Increase Atherogenicity of ApoE−/− and LDLR−/− Mouse LDL In Vitro Predicts its Atherogenic Role In Vivo , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[114]  S. Dudek,et al.  Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[115]  Takao Shimizu,et al.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. , 2009, Annual review of pharmacology and toxicology.

[116]  M. Gelb,et al.  Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA. , 2008, Bioorganic & medicinal chemistry letters.

[117]  M. Gelb,et al.  Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2. , 2008, Journal of medicinal chemistry.

[118]  M. Gelb,et al.  Biochemistry and physiology of mammalian secreted phospholipases A2. , 2008, Annual review of biochemistry.

[119]  D. Leduc,et al.  Edema Toxin Impairs Anthracidal Phospholipase A2 Expression by Alveolar Macrophages , 2007, PLoS pathogens.

[120]  M. Murakami,et al.  Human group III phospholipase A2 suppresses adenovirus infection into host cells. Evidence that group III, V and X phospholipase A2s act on distinct cellular phospholipid molecular species. , 2007, Biochimica et biophysica acta.

[121]  J. Bonventre,et al.  Deletion of Secretory Group V Phospholipase A2 Attenuates Cell Migration and Airway Hyperresponsiveness in Immunosensitized Mice1 , 2007, The Journal of Immunology.

[122]  S. Humphries,et al.  Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study. , 2007, Human molecular genetics.

[123]  James G. Bollinger,et al.  Importance of group X–secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model , 2007, The Journal of experimental medicine.

[124]  M. Gelb,et al.  Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. , 2007, Biochemistry.

[125]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[126]  J. Després,et al.  Abdominal obesity and metabolic syndrome , 2006, Nature.

[127]  M. Gelb,et al.  The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding. , 2006, Journal of medicinal chemistry.

[128]  K. Huggins,et al.  Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia. , 2006, Diabetes.

[129]  T. Spector,et al.  Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort , 2006, European Journal of Human Genetics.

[130]  M. Gelb,et al.  Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[131]  S. Humphries,et al.  Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study. , 2006, Human molecular genetics.

[132]  M. Mock,et al.  In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax1 , 2005, The Journal of Immunology.

[133]  W. Pruzanski,et al.  Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. , 2005, Biochimica et biophysica acta.

[134]  S. Myers,et al.  A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. , 2005, The Journal of rheumatology.

[135]  D. Friend,et al.  Lysophosphatidic acid accelerates the development of human mast cells. , 2004, Blood.

[136]  H. Huhtinen,et al.  Experimental Helicobacter felis Infection in Transgenic Mice Expressing Human Group IIA Phospholipase A2 , 2004, Helicobacter.

[137]  L. Touqui,et al.  High Bactericidal Efficiency of Type IIA Phospholipase A2 against Bacillus anthracis and Inhibition of Its Secretion by the Lethal Toxin1 , 2004, The Journal of Immunology.

[138]  H. Ueda,et al.  Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling , 2004, Nature Medicine.

[139]  M. Gelb,et al.  Arachidonic Acid Release from Mammalian Cells Transfected with Human Groups IIA and X Secreted Phospholipase A2 Occurs Predominantly during the Secretory Process and with the Involvement of Cytosolic Phospholipase A2-α* , 2004, Journal of Biological Chemistry.

[140]  H. Hammad,et al.  Prostaglandin D2 Inhibits Airway Dendritic Cell Migration and Function in Steady State Conditions by Selective Activation of the D Prostanoid Receptor 1 1 , 2003, The Journal of Immunology.

[141]  James G. Bollinger,et al.  Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. , 2003, Biochemistry.

[142]  K. Naresh,et al.  Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis , 2003, Oncogene.

[143]  Rui Li,et al.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[144]  K. Huggins,et al.  Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA2-deficient mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[145]  J. Deddens,et al.  Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[146]  M. Gelb,et al.  Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). , 2000, Biochemical and biophysical research communications.

[147]  M. Gelb,et al.  Novel Human Secreted Phospholipase A2 with Homology to the Group III Bee Venom Enzyme* , 2000, The Journal of Biological Chemistry.

[148]  N. Fujii,et al.  Structures, Enzymatic Properties, and Expression of Novel Human and Mouse Secretory Phospholipase A2s* , 2000, The Journal of Biological Chemistry.

[149]  M. Gelb,et al.  Exogenously Added Human Group X Secreted Phospholipase A2 but Not the Group IB, IIA, and V Enzymes Efficiently Release Arachidonic Acid from Adherent Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[150]  T. Nevalainen,et al.  Resistance of Transgenic Mice Expressing Human Group II Phospholipase A2 to Escherichia coliInfection , 2000, Infection and Immunity.

[151]  K. Kawamoto,et al.  Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia Cells* , 1999, The Journal of Biological Chemistry.

[152]  M. Gelb,et al.  On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. , 1999, The Journal of biological chemistry.

[153]  M. Murakami,et al.  Functional Association of Type IIA Secretory Phospholipase A2 with the Glycosylphosphatidylinositol-anchored Heparan Sulfate Proteoglycan in the Cyclooxygenase-2-mediated Delayed Prostanoid-biosynthetic Pathway* , 1999, The Journal of Biological Chemistry.

[154]  N. Fujii,et al.  Cloning and Characterization of Novel Mouse and Human Secretory Phospholipase A2s* , 1999, The Journal of Biological Chemistry.

[155]  M. Gelb,et al.  Cloning and Recombinant Expression of a Novel Mouse-secreted Phospholipase A2 * , 1999, The Journal of Biological Chemistry.

[156]  T. Nevalainen,et al.  Protection by group II phospholipase A2 against Staphylococcus aureus. , 1999, Journal of immunology.

[157]  M. Gelb,et al.  Roles of Trp31 in High Membrane Binding and Proinflammatory Activity of Human Group V Phospholipase A2 * , 1999, The Journal of Biological Chemistry.

[158]  M. Lazdunski,et al.  Receptors for a growing family of secreted phospholipases A2. , 1999, Trends in pharmacological sciences.

[159]  M. Lazdunski,et al.  Both Group IB and Group IIA Secreted Phospholipases A2 Are Natural Ligands of the Mouse 180-kDa M-type Receptor* , 1999, The Journal of Biological Chemistry.

[160]  M. Murakami,et al.  Functional Coupling Between Various Phospholipase A2s and Cyclooxygenases in Immediate and Delayed Prostanoid Biosynthetic Pathways* , 1999, The Journal of Biological Chemistry.

[161]  E. Dennis,et al.  Expression and characterization of human group V phospholipase A2. , 1998, Biochimica et biophysica acta.

[162]  M. Murakami,et al.  The Functions of Five Distinct Mammalian Phospholipase A2s in Regulating Arachidonic Acid Release , 1998, The Journal of Biological Chemistry.

[163]  Eric S. Lander,et al.  Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis , 1997, Nature Genetics.

[164]  M. Lazdunski,et al.  Cloning, Chromosomal Mapping, and Expression of a Novel Human Secretory Phospholipase A2 * , 1997, The Journal of Biological Chemistry.

[165]  D. R. Berry,et al.  Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides. , 1996, Journal of medicinal chemistry.

[166]  D. R. Berry,et al.  Indole inhibitors of human nonpancreatic secretory phospholipase A2. 2. Indole-3-acetamides with additional functionality. , 1996, Journal of medicinal chemistry.

[167]  W. Bodmer,et al.  Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours , 1996, Annals of human genetics.

[168]  C. F. Bennett,et al.  Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. , 1996, The Journal of clinical investigation.

[169]  G. Gyapay,et al.  Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human. , 1996, Genomics.

[170]  D. R. Berry,et al.  Indole inhibitors of human nonpancreatic secretory phospholipase A2. 1. Indole-3-acetamides. , 1996, Journal of medicinal chemistry.

[171]  J. Mudgett,et al.  A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains (*) , 1995, The Journal of Biological Chemistry.

[172]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[173]  G. Koski,et al.  Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery. , 1995, The Journal of clinical investigation.

[174]  J. Tischfield,et al.  Cloning, expression and partial characterization of a novel rat phospholipase A2. , 1994, Biochimica et biophysica acta.

[175]  J. Tischfield,et al.  Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2. , 1994, The Journal of biological chemistry.

[176]  H. Kawashima,et al.  Suppression of inflammatory responses to 12‐O‐tetradecanoylphorbol‐13‐acetate and carrageenin by YM‐26734, a selective inhibitor of extracellular group II phospholipase A2 , 1993, British journal of pharmacology.

[177]  J. J. Rosa,et al.  Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. , 1993, Science.

[178]  H. Teraoka,et al.  Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells , 1990, FEBS letters.

[179]  J. Seilhamer,et al.  Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. , 1986, DNA.

[180]  T. W. Martin,et al.  Interactions of lysophospholipids and mast cells , 1979, Nature.